600+ sources. One page. See who else covered it.
Wall Street analysts view the deal as a risky, high-reward bet on a treatment that’s nearing a possible regulatory approval and could be superior to existing medications.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Though previous LDF government had initiated the appointment process, it could not be completed due to various reasons
This proposal would require approval from Congress before it could be implemented.
In the Congo, the dangerous Ebola infection has already been detected in six provinces. Experts fear that if the outbreak is not stopped, it could also spread abroad.
A rare cancer diagnosis was terrifying, but the risk to Mr. Vieira's children "pulled the ground out from under my feet," he said.
Man dies in Bas-Uele after travelling from Haut-Uele, as head of WHO says outbreak on track to be deadliest ever The Ebola outbreak in the Democratic Republic of the Congo has spread to a sixth…
(MedPage Today) -- Public health experts have been quick to condemn an executive order from President Donald Trump aimed at upending childhood vaccinations in the U.S., but the biggest obstacles may…